Pharmaceutical Business Intelligence

  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204958

« Back to Dashboard
NDA 204958 describes KENGREAL, which is a drug marketed by Chiesi Usa Inc and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug. Additional details are available on the KENGREAL profile page.

The generic ingredient in KENGREAL is cangrelor. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the cangrelor profile page.

Summary for NDA: 204958

Formulation / Manufacturing:see details

Pharmacology for NDA: 204958

Mechanism of ActionP2Y12 Receptor Antagonists
Physiological EffectDecreased Platelet Aggregation

Suppliers and Packaging for NDA: 204958

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
POWDER;IV (INFUSION) 204958 NDA The Medicines Company 65293-003 65293-003-10 10 VIAL, SINGLE-USE in 1 CARTON (65293-003-10) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (65293-003-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;IV (INFUSION)Strength50MG/VIAL
Approval Date:Jun 22, 2015TE:RLD:Yes
Patent:9,295,687Patent Expiration:Jul 10, 2035Product Flag?YSubstance Flag?Delist Request?
Patent:9,427,448Patent Expiration:Nov 10, 2030Product Flag?Substance Flag?Delist Request?
Patent:9,439,921Patent Expiration:Jul 10, 2035Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.